Ibsrela (tenapanor)

photo of a green light on a stoplight
Pharma

Ardelyx's CKD med Xphozah wins FDA nod after long fight

After the FDA requested more data in 2021, Ardelyx instead defended its drug's profile through two appeals and an advisory committee meeting.
Zoey Becker Oct 18, 2023 8:35am
Mike Raab - Ardelyx

After pair of losses, Ardelyx's CKD prospect finds FDA foothold

Nov 17, 2022 8:05am
FDA

FDA flags concerns about Ardelyx's kidney disease prospect

Nov 15, 2022 10:48am
Hail May football catch

Ardelyx's last ditch tenapanor appeal successful

Apr 25, 2022 10:44am